ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 87 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $15,000 | -28.6% | 11,117 | -5.3% | 0.00% | – |
| Q4 2021 | $21,000 | -50.0% | 11,743 | -39.4% | 0.00% | – |
| Q3 2021 | $42,000 | -63.2% | 19,364 | -40.5% | 0.00% | – |
| Q2 2021 | $114,000 | -70.5% | 32,528 | -16.9% | 0.00% | – |
| Q1 2021 | $386,000 | -10.4% | 39,153 | -1.6% | 0.00% | – |
| Q4 2020 | $431,000 | +53.4% | 39,799 | +46.0% | 0.00% | – |
| Q3 2020 | $281,000 | -50.8% | 27,261 | -0.4% | 0.00% | -100.0% |
| Q2 2020 | $571,000 | +476.8% | 27,359 | +171.3% | 0.00% | – |
| Q1 2020 | $99,000 | -13.9% | 10,083 | -54.2% | 0.00% | – |
| Q1 2019 | $115,000 | +66.7% | 22,024 | +1.0% | 0.00% | – |
| Q4 2018 | $69,000 | -72.3% | 21,801 | -47.0% | 0.00% | – |
| Q3 2018 | $249,000 | +16.4% | 41,128 | +1.9% | 0.00% | – |
| Q2 2018 | $214,000 | – | 40,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |